OSE Immunotherapeutics SA (OSE.PA)
EUR 5.6
(0.63%)
EUR 5.6
(0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.76 Million | -18.25 Million | -9.91 Million | -19.55 Million | 8.97 Million | 1.07 Million |
| Net Income | -23 Million | -17.76 Million | -16.85 Million | -16.55 Million | -4.65 Million | 5.49 Million |
| Depreciation & Amortization | 3.47 Million | 3.55 Million | 2.6 Million | 730 Thousand | 482 Thousand | 116 Thousand |
| Deferred income taxes | -223 Thousand | -264 Thousand | -366 Thousand | -2.74 Million | 3.06 Million | -871 Thousand |
| Stock-based compensation | 2.03 Million | 3.13 Million | 3.77 Million | 2.28 Million | 1.86 Million | 845 Thousand |
| Change in working capital | -835 Thousand | -3.14 Million | 1.02 Million | -2.92 Million | 8.55 Million | -4.59 Million |
| Other non-cash items | 6.43 Million | -3.37 Million | -106.99 Thousand | -344 Thousand | -345 Thousand | -45 Thousand |
| Investing Cash Flow | -507 Thousand | 26 Thousand | -827 Thousand | -504 Thousand | 2.37 Million | -558 Thousand |
| Investments in PPE | -232 Thousand | -274 Thousand | -472 Thousand | -210 Thousand | -336 Thousand | -593 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -275 Thousand | - | - | - | - | - |
| Sales/Maturities of investments | - | 300 Thousand | - | - | 2.89 Million | 62 Thousand |
| Other Investing Activities | -491 Thousand | 300 Thousand | -355 Thousand | -294 Thousand | -184 Thousand | -27 Thousand |
| Financing Cash Flow | 13.32 Million | 10.26 Million | 14.95 Million | 23.58 Million | 4.92 Million | -592 Thousand |
| Debt repayment | -2.3 Million | -11.04 Million | -15.24 Million | -6.63 Million | -5.17 Million | -485 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -67 Thousand |
| Common Stock Issuance | 11.65 Million | 6000.00 | 265 Thousand | 17.42 Million | - | 30 Thousand |
| Other Financing Activities | -5.43 Million | 21.3 Million | 29.93 Million | 12.78 Million | 10.09 Million | -70 Thousand |
| Accounts receivables | 578 Thousand | -369 Thousand | -302 Thousand | -377 Thousand | 1.5 Million | 2.12 Million |
| Accounts payables | 759 Thousand | -1.06 Million | -679 Thousand | -3.36 Million | 363 Thousand | -2.22 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.17 Million | -1.7 Million | 2 Million | 825 Thousand | 6.68 Million | -4.49 Million |
| Cash at beginning of period | 25.62 Million | 33.57 Million | 29.36 Million | 25.84 Million | 4.47 Million | 9.64 Million |
| Cash at end of period | 18.67 Million | 25.62 Million | 33.57 Million | 29.36 Million | 25.84 Million | 9.57 Million |
| Capital Expenditure | -232 Thousand | -274 Thousand | -472 Thousand | -210 Thousand | -336 Thousand | -593 Thousand |
| Effect of forex changes on cash | -1000.00 | - | - | - | 5.09 Million | - |
| Net cash flow / Change in cash | -6.94 Million | -7.95 Million | 4.21 Million | 3.52 Million | 21.36 Million | -73 Thousand |
| Free Cash Flow | -19.99 Million | -18.52 Million | -10.39 Million | -19.76 Million | 8.63 Million | 484 Thousand |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 57.17 Million | -11.14 Million | -23 Million | -11.86 Million | -15.78 Million | -17.76 Million |
| Depreciation & Amortization | 1.66 Million | 541 Thousand | 3.47 Million | 1.82 Million | 1.77 Million | 3.55 Million |
| Deferred income taxes | - | -139 Thousand | -223 Thousand | -84 Thousand | -131 Thousand | -264 Thousand |
| Stock-based compensation | - | 472 Thousand | 2.03 Million | 1.56 Million | 1.94 Million | 3.13 Million |
| Change in working capital | 7.57 Million | 303 Thousand | -835 Thousand | -1.13 Million | -2.03 Million | -3.14 Million |
| Other non-cash items | 216.99 Thousand | 1.79 Million | 6.43 Million | 2.47 Million | 8.48 Million | -3.37 Million |
| Investing Cash Flow | -54.91 Million | -617 Thousand | -507 Thousand | 110 Thousand | -24 Thousand | 26 Thousand |
| Investments in PPE | -18 Thousand | -16 Thousand | -232 Thousand | - | -120 Thousand | -274 Thousand |
| Acquisitions | - | -62 Thousand | - | 62 Thousand | - | - |
| Investment purchases | -6000.00 | -275 Thousand | -275 Thousand | - | - | - |
| Sales/Maturities of investments | - | - | - | 48 Thousand | 96 Thousand | 300 Thousand |
| Other Investing Activities | -54.89 Million | -601 Thousand | -491 Thousand | 110 Thousand | 96 Thousand | 300 Thousand |
| Financing Cash Flow | -4.53 Million | 12.3 Million | 13.32 Million | 1.01 Million | 10.78 Million | 10.26 Million |
| Debt repayment | -4.32 Million | -1.3 Million | -2.3 Million | -996 Thousand | -11.19 Million | -11.04 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 215 Thousand | 11.17 Million | 11.65 Million | 487 Thousand | 6000.00 | 6000.00 |
| Other Financing Activities | -421 Thousand | 12.3 Million | -5.43 Million | 485.99 Thousand | 10.78 Million | 21.3 Million |
| Accounts receivables | -444 Thousand | 748 Thousand | 578 Thousand | -170 Thousand | -3000.00 | -369 Thousand |
| Accounts payables | -954 Thousand | -123 Thousand | 759 Thousand | 882 Thousand | -5.08 Million | -1.06 Million |
| Inventory | - | -1.04 Million | - | - | - | - |
| Other working capital | 8.97 Million | 303 Thousand | -2.17 Million | -1.85 Million | 3.05 Million | -1.7 Million |
| Cash at beginning of period | 18.67 Million | 15.01 Million | 25.62 Million | 25.62 Million | 31.19 Million | 33.57 Million |
| Cash at end of period | 75.74 Million | 18.67 Million | 18.67 Million | 15.01 Million | 25.62 Million | 25.62 Million |
| Capital Expenditure | -18 Thousand | -16 Thousand | -232 Thousand | - | -120 Thousand | -274 Thousand |
| Effect of forex changes on cash | - | -1000.00 | -1000.00 | 25.62 Million | -25.62 Million | - |
| Net cash flow / Change in cash | 57.07 Million | 3.65 Million | -6.94 Million | -10.6 Million | -5.57 Million | -7.95 Million |
| Free Cash Flow | 66.61 Million | -8.05 Million | -19.99 Million | -11.72 Million | -16.45 Million | -18.52 Million |
CHECKPOINT
KCC
6258
300760
KREN
1410